These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24331818)

  • 1. Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.
    Vaccarella S; Bruni L; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G32-44. PubMed ID: 24331818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
    Sancho-Garnier H; Khazraji YC; Cherif MH; Mahnane A; Hsairi M; El Shalakamy A; Osgul N; Tuncer M; Jumaan AO; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G51-7. PubMed ID: 24331820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review.
    Seoud M
    J Low Genit Tract Dis; 2012 Apr; 16(2):106-20. PubMed ID: 22371041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.
    Jumaan AO; Ghanem S; Taher J; Braikat M; Al Awaidy S; Dbaibo GS
    Vaccine; 2013 Dec; 31 Suppl 6():G58-64. PubMed ID: 24331821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
    Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
    Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexuality and sexual health: constructs and expressions in the extended Middle East and North Africa.
    El-Kak F
    Vaccine; 2013 Dec; 31 Suppl 6():G45-50. PubMed ID: 24331819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
    Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
    J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
    Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended Middle East and North Africa: summary recommendations for the prevention of human papillomavirus infections and related cancers including cervical cancer.
    Seoud M; Vaccarella S; El-Kak F; Sancho-Garnier H; Jumaan AO; Kim JJ; Garland SM; Stern PL; LaMontagne DS; Albero G; Bosch FX
    Vaccine; 2013 Dec; 31 Suppl 6():G78-9. PubMed ID: 24331823
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region?
    Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():vii-viii. PubMed ID: 24331825
    [No Abstract]   [Full Text] [Related]  

  • 20. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
    Clifford G; Franceschi S; Diaz M; Muñoz N; Villa LL
    Vaccine; 2006 Aug; 24 Suppl 3():S3/26-34. PubMed ID: 16950015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.